Skip to content

Efficacy of Chinese Herbal Tea in the Prevention of Novel Coronavirus Pneumonia (COVID-19): a Randomized Controlled Trial

Efficacy of Chinese Herbal Tea in the Prevention of Novel Coronavirus Pneumonia (COVID-19) for Returning Workers in Wuhan: a Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000031944
Enrollment
Unknown
Registered
2020-04-15
Start date
2020-04-16
Completion date
Unknown
Last updated
2020-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Sponsors

China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Both male and female, 18 years old <= aged <= 75 years old; (2) The territory is limited to wuhan, hubei province; (3) Voluntarily participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) People with severe primary diseases such as heart, brain, liver, kidney and hematopoietic system; (2) People with pulmonary malignancy; (3) Combined with mental, intellectual or language disorders; (4) Pregnant women, lactating women and those who have pregnancy requirement in the last 6 months; (5) People who cannot skillfully use mobile phones or computers to fill in the questionnaire; (6) People who are not willing to accept Chinese herbal tea, or those who have a history of allergy to Chinese herbal medicine; (7) People who are using other Chinese herbal tea; (8) People who had been diagnosed with covid-19 and recovered.

Design outcomes

Primary

MeasureTime frame
the rate of 2019-nCoV RNA positive;

Secondary

MeasureTime frame
body temperature;symptom;

Countries

China

Contacts

Public ContactLu Cheng
lv_cheng0816@163.com+86 010-64093264

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026